Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1397 Neoplasms 1129 Prostatic Neoplasms 744 Lung Neoplasms 619 Colorectal Neoplasms 596 Carcinoma, Non-Small-Cell Lung 569 Carcinoma, Hepatocellular 413 Pancreatic Neoplasms 402 Leukemia, Myeloid, Acute 398 Stomach Neoplasms 355 Multiple Myeloma 326 Brain Neoplasms 311 Ovarian Neoplasms 309 Head and Neck Neoplasms 289 Neoplasm Metastasis 273 Precursor Cell Lymphoblastic Leukemia-Lymphoma 260 Rectal Neoplasms 253 Uterine Cervical Neoplasms 248 Recurrence 248 Melanoma 242 Esophageal Neoplasms 237 Glioblastoma 232 Squamous Cell Carcinoma of Head and Neck 231 Lymphoma 213 Sarcoma 207 Urinary Bladder Neoplasms 192 Colonic Neoplasms 192 Glioma 191 Triple Negative Breast Neoplasms 188 Hematologic Neoplasms 183

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Pancreatic Cystic Neoplasm × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡